Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis (Q33637615)

28 July 2017

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis (English)

1 reference

28 July 2017

0 references

1 reference

6

A Bruce Montgomery

1 reference

28 July 2017

George Z Retsch-Bogart

1

1 reference

28 July 2017

Alexandra L Quittner

2

1 reference

28 July 2017

Ronald L Gibson

3

1 reference

28 July 2017

Christopher M Oermann

4

1 reference

28 July 2017

Karen S McCoy

5

1 reference

28 July 2017

Peter J Cooper

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

28 July 2017

1 reference

28 July 2017

135

1 reference

28 July 2017

5

1 reference

28 July 2017

1223-1232

1 reference

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Patient-reported outcomes in cystic fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Making sense of quality-of-life data.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Microbiology of sputum from patients at cystic fibrosis centers in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Changes in the normal maximal expiratory flow-volume curve with growth and aging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Measurement of health status. Ascertaining the minimal clinically important difference

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Validation of a Disease-Specific Measure of Health-Related Quality of Life for Children with Cystic Fibrosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818415

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19420195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19420195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1378/CHEST.08-1421

1 reference

28 July 2017

1 reference

28 July 2017

1 reference